Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #35,651 to #35,700.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Nephron (2 revisions)
  2. Nepinalone (2 revisions)
  3. Nerve agent (2 revisions)
  4. Nessler's reagent (2 revisions)
  5. Netrin 1 (2 revisions)
  6. Network effect (2 revisions)
  7. Neural cell adhesion molecule (2 revisions)
  8. Neural tube defect (2 revisions)
  9. Neuralgia epidemiology and demographics (2 revisions)
  10. Neuralgia laboratory findings (2 revisions)
  11. Neuralgia other diagnostic studies (2 revisions)
  12. Neuregulin 3 (2 revisions)
  13. Neurobiology (2 revisions)
  14. Neuroblastoma primary prevention (2 revisions)
  15. Neuroblastoma secondary prevention (2 revisions)
  16. Neurocardiology (2 revisions)
  17. Neurochemistry (2 revisions)
  18. Neuroendocrine tumors other diagnostic studies (2 revisions)
  19. Neurofibrillary tangle (2 revisions)
  20. Neurofibroma future or investigational therapies (2 revisions)
  21. Neurofibromatosis type 1 echocardiography and ultrasound (2 revisions)
  22. Neurofibromatosis type 1 electrocardiogram (2 revisions)
  23. Neurofibromatosis type 1 interventions (2 revisions)
  24. Neurofibromatosis type 1 other diagnostic studies (2 revisions)
  25. Neurofibromatosis type 1 overview (2 revisions)
  26. Neurofibromatosis type 1 primary prevention (2 revisions)
  27. Neuroglycopenia history and symptoms (2 revisions)
  28. Neurogranin (2 revisions)
  29. Neuroimaging (2 revisions)
  30. Neuromarketing (2 revisions)
  31. Neuromedin B receptor (2 revisions)
  32. Neuromedin N (2 revisions)
  33. Neuromedin U receptor (2 revisions)
  34. Neuromuscular blocking drugs (2 revisions)
  35. Neuromyelitis optica spectrum disorder (patient information) (2 revisions)
  36. Neuromyelitis optica spectrum disorder electrocardiogram (2 revisions)
  37. Neuromyelitis optica spectrum disorder epidemiology and demographics (2 revisions)
  38. Neuromyelitis optica spectrum disorder future or investigational therapies (2 revisions)
  39. Neuromyelitis optica spectrum disorder physical examination (2 revisions)
  40. Neuromyelitis optica spectrum disorder screening (2 revisions)
  41. Neuromyotonia (2 revisions)
  42. Neuron (2 revisions)
  43. Neuronal PAS domain protein 4 (2 revisions)
  44. Neuronal calcium sensor-1 (2 revisions)
  45. Neuropathy target esterase (2 revisions)
  46. Neuropeptide B (2 revisions)
  47. Neuropeptide FF (2 revisions)
  48. Neuropeptide S receptor (2 revisions)
  49. Neuropilin (2 revisions)
  50. Neuroplasticity (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"